50
Views
14
CrossRef citations to date
0
Altmetric
Original Articles

Longer Duration of HBV-Active Antiretroviral Therapy is Linked to Favorable Virological Outcome in HIV-HBV Co-infected Patients

&
Pages 153-159 | Published online: 06 Jan 2015

REFERENCES

  • Nunez M, Soriano V. Management of patients co-infected with hepatitis B virus and HIV. Lancet Infect Dis. 2005;5:374–382.
  • Shire NJ, Sherman KE. Management of HBV/HIV-coinfected patients. Semin Liver Dis. 2005;25(Suppl 1):48–57.
  • Puoti M, Torti C, Bruno R, Filice G, Carosi G. Natural history of chronic hepatitis B in co-infected patients. J HepatoL 2006;44(1 Suppl):565–70.
  • Thio C, Locarnini S. Treatment of HIV/HBV co-infection: clinical and virological issues. AIDS Rev. 2007;9:40–53.
  • Nunez M, Belen R, Diaz-Pollan B, et al. Virological outcome of chronic hepatitis B virus infection in HIV-coinfected patients receiving anti-HBV active antiretroviral therapy. AIDS Res Hum Retro virus. 2006;22:842–848.
  • Miailhes P, Trabaud MA, Pradat P, et al. Impact of highly active antiretroviral therapy (HAART) on the natural history of hepatitis B virus (HBV) and HIV coinfection: relation-ship between prolonged efficacy of HAART and HBV surface and early antigen seroconversion. Clin Infect Dis. 2007;45:624–632.
  • Sheng WH, Kao JH, Chen PJ, et al. Evolution of hepatitis B serological markers in HIV-infected patients receiv-ing highly active antiretroviral therapy. Clin Infect Dis. 2007;45:1221–1229.
  • Strader DB, Wright T, Thomas DL, Seeff LB. Diagnosis, management, and treatment of hepatitis C. Hepatology. 2004;39(4)1147–1171.
  • Chu CJ, Keeffe EB, Han SH, et al. Hepatitis B virus geno-types in the United States: results of a nationwide study. Gastroenterology. 2003;125:444–451.
  • Bartlett JA. Addressing the challenges of adherence. J Acquir Immune Defic Syndr 2002; 29(Suppl 1):52–10.
  • Thio C, Seaberg E, Skolasky R, Phair J, Visscher B, Munoz A, Thomas DL, Multicenter AIDS Cohort Study. HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter AIDS Cohort Study (MACS). Lancet. 2002;360:1921–1926.
  • Di Martino V, Thevenot T, Colin JF, et al. Influence of HIV infection on the response to interferon therapy and the long-term outcome of chronic hepatitis B. Gastroenterology. 2002;123:1812–1822.
  • Bonacini M, Bzowej N, Louie S, Wohl AR. Survival in patients with HIV infection and viral hepatitis B or C. AIDS. 2004;18:2039–2045.
  • Sheng WH, Chen MY, Hsieh SM, et al. Impact of chronic hepatitis B virus (HBV) infection on outcomes of patients infected with HIV in an area where HBV infection is hyper-endemic. Clin Infect Dis. 2004;38:1471–1477.
  • Konopnicki D, Mocroft A, de Wit S. Hepatitis B and HIV: prevalence, AIDS progression, response to HAART and increased mortality in the EuroSIDA cohort. AIDS. 2005;19:2117–2125.
  • Lascar RM, Lopes AR, Gilson RJ, et al. Effect of HIV infec-tion and antiretroviral therapy on hepatitis B virus (HBV)-specific T cell responses in patients who have resolved HBV infection. J Infect Dis. 2005;191:1169–1179.
  • Wursthorn K, Buggisch P, Lutgehetmann M, Zollner B, Petersen J. Temporary HBV resolution in an HIV-co-infected patient during HBV-directed combination therapy followed by relapse of HBV. Antivir Ther 2006;11:647–652.
  • Rouphael NG, Talati NJ, Rimland D. Hepatitis B reverse seroconversion in HIV-positive patients: case series and review of the literature. AIDS. 2007;21:771–774.
  • Brat N, Fox RK,Xiao P. Presentation and outcome of hepato-cellular carcinoma in HIV-infected patients: a US-Canadian multicenter study. J Hepatol. 2007;47:527–537.
  • Lloeje UH, Yang HI, Su J, et al. Predicting cirrhosis risk based on the level of circulating hepatitis B viral load. REVEAL-HBV Study Group. Gastroenterology. 2006;130:678–686.
  • Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology. 2007;45:507–539.
  • Bonacini M, Louie S, Bzowej N, Wohl AR. Survival in patients with HIV infection and viral hepatitis B or C: a cohort study. AIDS. 2004;18(15):2039–2045.
  • Peters MG. Diagnosis and management of hepatitis B virus and HIV coinfection. Top HIV Med. 2007;15:163–166.
  • Sulkowski MS. Management of hepatic complications in HIV-infected persons. J Infect Dis. 2008;197(Suppl 3):S279—S293.
  • Soriano V, Puoti M, Peters M, et al. Care of HIV patients with chronic hepatitis B: updated recommendations from the HIV-Hepatitis B Virus International Panel. AIDS. 2008; 22:1399–1410.
  • Iser DM, Sasadeusz J. Current treatment of HIV/hep-atitis B virus coinfection. J Gastroenterol Hepatol. 2008;23:699–706.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.